An assessment system for clinical and biological interpretability in ulcerative colitis

被引:0
作者
Zhang, Shiqian [1 ]
Zhang, Ge [2 ,3 ]
Wang, Wenxiu [4 ]
Guo, Song-Bin [5 ,6 ]
Zhang, Pengpeng [7 ]
Wang, Fuqi [1 ]
Zhou, Quanbo [1 ]
Zhou, Zhaokai [8 ]
Wang, Yujia [2 ,3 ]
Sun, Haifeng [1 ]
Cui, Wenming [1 ]
Yang, Shuaixi [1 ]
Yuan, Weitang [1 ]
机构
[1] Zhengzhou Univ, Affiliated Hosp 1, Dept Colorectal Surg, Zhengzhou 450052, Henan, Peoples R China
[2] Zhengzhou Univ, Affiliated Hosp 1, Dept Cardiol, Zhengzhou 450052, Henan, Peoples R China
[3] Henan Prov Clin Res Ctr Cardiovasc Dis, Zhengzhou 450052, Henan, Peoples R China
[4] Zhengzhou Univ, Affiliated Hosp 3, Dept Neonatol, Zhengzhou 450052, Henan, Peoples R China
[5] Sun Yat Sen Univ, Canc Ctr, Dept Med Oncol, Guangzhou 510060, Guangdong, Peoples R China
[6] Sun Yat Sen Univ, Canc Ctr, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou 510060, Guangdong, Peoples R China
[7] Nanjing Med Univ, Affiliated Hosp 1, Dept Thorac Surg, Nanjing 210029, Jiangsu, Peoples R China
[8] Zhengzhou Univ, Affiliated Hosp 1, Dept Urol, Zhengzhou 450052, Henan, Peoples R China
来源
AGING-US | 2024年 / 16卷 / 04期
基金
中国国家自然科学基金;
关键词
machine learning; diagnosis model; regulatory landscape; computational biology; biological interpretability; INFLAMMATORY-BOWEL-DISEASE; RANDOM FOREST; EXPRESSION; DIAGNOSIS; CLASSIFICATION; MECHANISMS;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Ulcerative colitis (UC) is a serious inflammatory bowel disease (IBD) with high morbidity and mortality worldwide. As the traditional diagnostic techniques have various limitations in the practice and diagnosis of early ulcerative colitis, it is necessary to develop new diagnostic models from molecular biology to supplement the existing methods. In this study, we developed a machine learning -based synthesis to construct an artificial intelligence diagnostic model for ulcerative colitis, and the correctness of the model is verified using an external independent dataset. According to the significantly expressed genes related to the occurrence of UC in the model, an unsupervised quantitative ulcerative colitis related score (UCRScore) based on principal coordinate analysis was established. The UCRScore is not only highly generalizable across UC bulk cohorts at different stages, but also highly generalizable across single-cell datasets, with the same effect in terms of cell numbers, activation pathways and mechanisms. As an important role of screening genes in disease occurrence, based on connectivity map analysis, 5 potential targeting molecular compounds were identified, which can be used as an additional supplement to the therapeutic of UC. Overall, this study provides a potential tool for differential diagnosis and assessment of bio-pathological changes in UC at the macroscopic level, providing an opportunity to optimize the diagnosis and treatment of UC.
引用
收藏
页码:3856 / 3879
页数:24
相关论文
共 50 条
  • [31] The prognostic value of histology in ulcerative colitis in clinical remission with mesalazine
    Frieri, Giuseppe
    Galletti, Brigida
    Di Ruscio, Mirko
    Tittoni, Rachele
    Capannolo, Annalisa
    Serva, Donatella
    Latella, Giovanni
    Sollima, Laura
    Leocata, Pietro
    Necozione, Stefano
    Frieri, Rosamarie
    Viscido, Angelo
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2017, 10 (10) : 749 - 759
  • [32] The effect of body weight on the severity and clinical course of ulcerative colitis
    Stabroth-Akil, Denia
    Leifeld, Ludger
    Pfuetzer, Roland
    Morgenstern, Julia
    Kruis, Wolfgang
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2015, 30 (02) : 237 - 242
  • [33] The Demographic and Clinical Characteristics of Ulcerative Colitis in a Northeast Brazilian Population
    da Silva, Bruno Cesar
    Lyra, Andre Castro
    Cardeal Mendes, Carlos Mauricio
    Oliveira Ribeiro, Camila Paula
    Oliveira Lisboa, Sonyara Rauedys
    Lordello de Souza, Mariana Tinoco
    Portela, Renata Cavalcanti
    Santana, Genoile Oliveira
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [34] French national consensus clinical guidelines for the management of ulcerative colitis
    Peyrin-Biroulet, Laurent
    Bouhnik, Yoram
    Roblin, Xavier
    Bonnaud, Guillaume
    Hagege, Herve
    Hebuterne, Xavier
    DIGESTIVE AND LIVER DISEASE, 2016, 48 (07) : 726 - 733
  • [35] Staging Pouch Surgery in Ulcerative Colitis in the Biological Era
    Risto, Anton
    Abdalla, Maie
    Myrelid, Par
    CLINICS IN COLON AND RECTAL SURGERY, 2022, 35 (01) : 58 - 65
  • [36] The safety of non-biological treatments in Ulcerative Colitis
    Troncone, Edoardo
    Monteleone, Giovanni
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (07) : 779 - 789
  • [37] Distinguishing between Crohn's disease and ulcerative colitis using deep learning models with interpretability
    Mauricio, Jose
    Domingues, Ines
    PATTERN ANALYSIS AND APPLICATIONS, 2024, 27 (01)
  • [38] Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Infection Rates from the Ulcerative Colitis Clinical Programme
    Winthrop, Kevin L.
    Loftus, Edward V. Jr Jr
    Baumgart, Daniel C.
    Reinisch, Walter
    Nduaka, Chudy, I
    Lawendy, Nervin
    Chan, Gary
    Mundayat, Rajiv
    Friedman, Gary S.
    Salese, Leonardo
    Thorpe, Andrew J.
    Su, Chinyu
    JOURNAL OF CROHNS & COLITIS, 2021, 15 (06) : 914 - 929
  • [39] Pharmacodynamic assessment of vedolizumab for the treatment of ulcerative colitis
    McLean, Leon P.
    Cross, Raymond K.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2016, 12 (07) : 833 - 842
  • [40] Assessment of disease activity in pediatric ulcerative colitis
    Kolho, Kaija-Leena
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 10 (10) : 1127 - 1134